Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
HQIP is proposing to tender the delivery of five new cancer audit topics under a single contract for a National Cancer Audit Collaborating Centre, with confirmation of this intent to be informed by a period of active market engagement prior to tender launch.
The Market Engagement Questionnaire and draft Specification will be open to organisations to provide their feedback on the HQIP's e-tendering platform 'Wax' https://s2c.waxdigital.co.uk/HQIP/SignIn.aspx. It is anticipated that this will be available from 1st September 2021 to 14 September 2021.
HQIP is seeking to procure the service provision of 5 national clinical audits to improve care quality and outcomes and reduce unwarranted variation in the following clinical areas:
Metastatic Breast Cancer
Ovarian Cancer
Pancreatic Cancer
Non-Hodgkin Lymphoma
Renal Cancer
Short Description
HQIP anticipates including all five topics under a single contract for a National Cancer Audit Collaborating Centre, with confirmation of this intent to be informed by a period of active market engagement prior to tender launch. The contract would be for three years with potential to extend for an additional two years.
The value of the contract is anticipated to be to a maximum of circa £1.5 million per annum excluding VAT.
Additional information: HQIP will update the procurement webpage at the start of the market engagement period with details relevant to the anticipated contract opportunity.
No supplier information available.